ProBioGen AG

General information

ProBioGen AG
Herbert-Bayer-Strasse 8
13086 Berlin, Berlin
Germany

Contact person: Andrea Hauptmann, Chief Financial Officer
Company main phone: ++49 (30) 322935100
Website: http://www.probiogen.de

Year founded:	1994
Source of foundation:	Spin-off from public institution / NPO
Name of foundation source:	Charité
No. of employees:	At this location: 300

Corporate description / mission:
ProBioGen AG is a contract development and manufacturing organization (CDMO) and technology provider. The company performs cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. The company offers proprietary technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines.

State of ownership: Private / independent
Headquarters: HQ: No

Remarks on ownership / listings
As of June 14, 2010, ProBioGen AG operates as a subsidiary of MINAPHARM Pharmaceuticals S.A.E.

Categorization

Sector:

Biotechnology - R&D Services

Subsector:

Analytical services
Cell culture
CMO (Contract Manufacturing Organization)
Proteomics

Business model:

Research on contract basis
Service company
Subsidiary

Customer segments:

Large biotech & big pharma
Small biotech

Summary Products / Services / Technologies

Description of products:
GMP Production Cell Lines
Process Development
Virus Production Development, etc.

Technology used:
GlymaxX® technology
DirectedLuck® Transposase
MVA Platform

Collaborations & Clients

Partnering strategy / collaborations:
Thermo Fisher Scientific
Boehringer Ingelheim